|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Cash flows from Operating activities: | |||
| Net loss | |||
| Adjustments to reconcile net loss to net cash used in operations | |||
| Stock-based compensation expense | |||
| Issuance of common stock for services | |||
| Credit loss expenses - loan due from related party | |||
| Loss on extinguishment of debt | |||
| Amortization of debt issuance costs | |||
| Change in operating assets and liabilities: | |||
| Prepaid expenses | |||
| Trade accounts payable and accrued liabilities | |||
| Due to related parties | |||
| Accrued compensation - officer | |||
| Net cash used in operating activities | |||
| Cash flows from Financing activities: | |||
| Payment of deferred offering costs | |||
| Payments under related party line of credit | |||
| Borrowings from related party | |||
| Borrowings under related party line of credit | |||
| Repayment from officer | |||
| Proceeds from warrant exercise | |||
| Proceeds from sale of common stock, related party | |||
| Net proceeds from sale of common stock | |||
| Net cash provided by financing activities | |||
| Net change in cash | |||
| Cash, beginning of year | |||
| Cash, end of year | |||
| Supplemental disclosure of cash flow information: | |||
| Non-cash investing and financing activities: | |||
| Issuance of warrants on related party line of credit | |||
| Accrued offering expense | |||
| Debt conversion to common stock | |||
| Advances to affiliates | |||
| Deferred offering costs charged to additional paid-in capital |
Loading...